Limited Period Offer:Be a PRO for 1 month @Rs49/-Multiple payment options available. Know More

business

No scope of US intervention in Indian pharma cos: Wockhardt

Wockhardt chief Habil Khorakiwala says that Indian generic company as a whole is a competitive industry in US and therefore there is no scope for government intervention there. Anmol Ganjoo of JM Financial says if drug prices come down then Indian pharma companies will benefit.

LATEST VIDEOS

Watch More →

A collection of the most-viewed Moneycontrol videos.

Watch and Follow our leading shows

Sections